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nositol 1,4,5-trisphosphate (InsP
 
3
 
) receptors (InsP
 
3
 
Rs) are
channels responsible for calcium release from the endo-
plasmic reticulum (ER). We show that the anti-apoptotic
protein Bcl-2 (either wild type or selectively localized to
the ER) significantly inhibited InsP
 
3
 
-mediated calcium release
and elevation of cytosolic calcium in WEHI7.2 T cells. This
inhibition was due to an effect of Bcl-2 at the level of
InsP
 
3
 
Rs because responses to both anti-CD3 antibody and
a cell-permeant InsP
 
3
 
 ester were decreased. Bcl-2 inhibited
the extent of calcium release from the ER of permeabilized
I
 
WEHI7.2 cells, even at saturating concentrations of InsP
 
3
 
,
without decreasing luminal calcium concentration. Further-
more, Bcl-2 reduced the open probability of purified
InsP
 
3
 
Rs reconstituted into lipid bilayers. Bcl-2 and InsP
 
3
 
Rs
were detected together in macromolecular complexes by
coimmunoprecipitation and blue native gel electrophoresis.
We suggest that this functional interaction of Bcl-2 with
InsP
 
3
 
Rs inhibits InsP
 
3
 
R activation and thereby regulates
InsP
 
3
 
-induced calcium release from the ER.
 
Introduction
 
Inositol 1,4,5-trisphosphate (InsP
 
3
 
) receptors (InsP
 
3
 
Rs) are
ligand-gated calcium channels located on the ER (Patel et
al., 1999; Taylor et al., 1999). These receptors are wide-
spread in distribution and constitute a family of calcium
channels with three main subtypes sharing similar but not
identical functional properties. InsP
 
3
 
-induced channel open-
ing releases calcium from the ER lumen into the cytosol,
generating calcium signals that regulate a wide range of
cellular processes, including cell proliferation and apoptosis
(Berridge et al., 2003). For example, in T cells, InsP
 
3
 
-induced
calcium elevation activates calcineurin-mediated signaling
pathways leading to both cell proliferation and apoptosis
(Crabtree, 1999). InsP
 
3
 
Rs are necessary for apoptosis induction
by glucocorticosteroids and ionizing radiation in T cells
(Khan et al., 1996; Jayaraman and Marks, 1997) and by surface
IgM ligation in B cells (Sugawara et al., 1997). Calcium acti-
vates a variety of apoptosis effectors, including calcineurin,
endonucleases, phospholipases, and proteases (for review see
Hajnoczky et al., 2003; Orrenius et al., 2003). Also, InsP
 
3
 
-
linked calcium signals may trigger apoptosis by disturbing
mitochondrial function (Szalai et al., 1999; Pinton et al., 2001;
Pacher and Hajnoczky, 2001). Recently, it has been reported
that cytochrome 
 
c
 
, released from mitochondria, binds to
InsP
 
3
 
Rs, inducing calcium release from the ER and amplify-
ing calcium-dependent apoptosis (Boehning et al., 2003).
Bcl-2 is the founding member of a large family of proteins
that regulate apoptosis from critical control points on both
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mitochondria and the ER (Cory and Adams, 2002; Danial
and Korsmeyer, 2004). Bcl-2 is an integral membrane pro-
tein that localizes to both the ER and mitochondria (Kauf-
mann et al., 2003). Although a significant proportion of
Bcl-2 is on the ER (Kaufmann et al., 2003), its role in inhib-
iting cytochrome 
 
c
 
 release from mitochondria has been em-
phasized (Green and Reed, 1998; Gross et al., 1999). Recent
findings indicate that Bcl-2 localized specifically on the ER
also inhibits cytochrome 
 
c
 
 release and apoptosis in response
to a variety of signals (Zhu et al., 1996; Hacki et al., 2000;
Wang et al., 2001; Thomenius et al., 2003).
Previous studies have shown that changes in cellular cal-
cium signaling can dramatically modulate the induction of
apoptosis (for review see Hajnoczky et al., 2003; Orrenius et
al., 2003). It has been proposed that the action of Bcl-2 is
mediated in part due to its ability to regulate cytosolic and
mitochondrial calcium changes. For example, it was demon-
strated a decade ago that Bcl-2 dampens calcium oscillations
and prevents redistribution of calcium from ER to mito-
chondria after growth factor withdrawal (Baffy et al., 1993;
Magnelli et al., 1994). However, the absolute effect of Bcl-2
is unclear, with changes in cytosolic, ER, and mitochondrial
calcium signaling being reported in different studies (Lam et
al., 1994; Zornig et al., 1995; Marin et al., 1996; Ichimiya
et al., 1998; Zhu et al., 1999; Williams et al., 2000; Pinton
et al., 2001). Furthermore, the mechanism by which Bcl-2
interacts with calcium signaling systems is controversial.
This is exemplified by the conflicting reports about Bcl-2’s
effect on ER luminal calcium. We, and others, have pro-
vided evidence that Bcl-2 preserves luminal calcium, whereas
several recent papers suggest that Bcl-2 increases leakage of
calcium from the ER and decreases luminal calcium (for re-
view see Distelhorst and Shore, 2004).
The present study was undertaken to test the hypothesis
that Bcl-2 on the ER regulates InsP
 
3
 
-linked calcium signals
that mediate cell cycle entry and apoptosis. We report that
Bcl-2 inhibits InsP
 
3
 
-induced calcium release from the ER by
impeding calcium release through InsP
 
3
 
Rs. This action of
Bcl-2 was not due to an alteration in InsP
 
3
 
R expression or
luminal calcium concentration, but was mediated through a
functional interaction of Bcl-2 with InsP
 
3
 
Rs that inhibited
their channel opening in response to InsP
 
3
 
.
 
Results
 
Bcl-2 inhibits anti-CD3–induced calcium elevation
 
To investigate the effect of Bcl-2 on calcium homeostasis,
the T cell receptor (TCR)–positive WEHI7.2 line was stably
transfected with an expression vector encoding human Bcl-2
or empty control vector. Bcl-2 was not detected in nontrans-
fected cells or in empty vector transfected control clones
(Fig. 1 A; N1 and N2), but was readily detectable in Bcl-2–
positive clones (Fig. 1 A; B1, B13, B17, and B27). Bcl-2 ex-
pression was monitored frequently by flow cytometry and
only cultures with more than 85% of Bcl-2–positive cells
were used in experiments. Bcl-2 expression conferred resis-
tance to apoptosis induction by dexamethasone, staurospo-
rine, and thapsigargin (TG; unpublished data). Substantial
differences were not detected in the expression levels of
InsP
 
3
 
Rs (Fig. 1 B), SERCA pumps (Fig. 1 C), or luminal
calcium binding proteins (not depicted).
Antibody to the CD3 component of the TCR induced a
calcium elevation in control WEHI7.2 cells that was inhib-
ited in Bcl-2–transfected cells (Fig. 2 A). Bcl-2 expression
also reduced both the number of cells responding to anti-
CD3 antibody (Fig. 2 B) and the amplitude of calcium ele-
vation in responding cells (Fig. 2 C). In addition, Bcl-2
expression appeared to increase the latency up to 2 min be-
tween the time when anti-CD3 antibody was added and
when the elevation of cytosolic calcium was first detected.
The inhibitory effect of Bcl-2 on anti-CD3–induced cal-
cium elevation was confirmed by directly comparing multi-
ple Bcl-2–negative and –positive clones (Fig. 3, A and C).
Also, Bcl-2 selectively targeted for expression on the ER in-
hibited anti-CD3–induced calcium elevation (Fig. 3 E).
 
ER calcium levels are not affected by Bcl-2 expression
 
We investigated several possible mechanisms by which Bcl-2
expression could decrease agonist-induced calcium signals.
First, we tested whether or not Bcl-2 expression affected ER
calcium levels. This test was performed by two complemen-
tary approaches: (1) quantitation of the TG releasable cal-
cium pool and (2) direct measurement of free luminal cal-
cium concentration. TG inhibits SERCA pumps and causes
a passive leak of calcium from ER lumen into cytoplasm.
Figure 1. Characterization of Bcl-2–positive and –negative clones. 
Western blot of cell lysates from nontransfected (wild type, WT) 
WEHI7.2 cells, control clones transfected with empty vector (N1 
and N2), and clones stably expressing full-length Bcl-2 (B1, B13, 
B17, and B27). (A) The blot was probed with anti–hBcl-2 (human 
Bcl-2) antibody, then reprobed with anti-actin antibody to control 
for loading. (B) Blots were probed with antibodies to InsP3Rs I and III. 
(C) Blots were probed with antibodies to SERCA3, then reprobed 
with anti-actin antibody to control for loading.
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TG-induced calcium elevation is an indirect measure of ER
calcium content. We found no difference in the magnitude
of the TG releasable calcium pool (Fig. 3, B, D, and F).
Therefore, absence of an effect of Bcl-2 on TG-induced cal-
cium elevation suggests that the inhibitory effect of Bcl-2 on
anti-CD3–induced calcium elevation is not secondary to a
Bcl-2–imposed decrease in ER luminal calcium concentra-
tion.
Luminal calcium concentration was measured directly us-
ing the low affinity calcium-sensitive dye Fura-2FF AM.
Optimal conditions for loading Fura-2FF AM into the ER
were determined in preliminary experiments. The organelle
distribution of Fura-2FF fluorescence was in a reticular pat-
tern distinct from the punctate mitochondrial pattern de-
tected with the potentiometric dye tetramethylrhodamine
ethyl ester (TMRE; Fig. 4 A). To quantify the relative
amount of Fura-2FF localized to the ER lumen, the plasma
membrane was permeabilized with digitonin and cells were
perfused with intracellular buffer (ICB) supplemented with
an ATP-regenerating system, 10 
 

 
M InsP
 
3
 
, and 100 
 

 
M
MnCl
 
2
 
 (Fig. 4 B). The initial decrease in the emission inten-
sity at both 340 and 380 nm excitation (at 
 

 
80 s) signifies
the point at which the plasma membrane is permeabilized.
The subsequent decrease in 340 and 380 nm emission (at
 

 
190 s) is due to InsP
 
3
 
-induced opening of InsP
 
3
 
Rs on the
ER, allowing MnCl
 
2
 
 to enter the ER lumen. Fura-2FF has
high affinity for MnCl
 
2
 
, which in turn quenches the dye. In
multiple experiments, more than 90% of the fluorescence
remaining after digitonin permeabilization was quenched by
perfusing cells with 10 
 

 
M InsP
 
3
 
 and 100 
 

 
M MnCl
 
2
 
. Us-
ing this assay system, ER luminal calcium concentration was
Figure 2. Inhibition of CD3/TCR-mediated calcium elevation by 
Bcl-2. Cytosolic calcium concentration was measured by single cell 
calcium imaging using the calcium indicator Fura-2 AM in the 
presence of 1.3 mM extracellular calcium. (A) Representative calcium 
traces comparing Bcl-2–negative (N1) and –positive (B27) clones. 
(B) The number of cells responding or failing to respond with a 
significant increase in cytoplasmic calcium concentration twofold 
above baseline after exposure to anti-CD3 antibody. (C) Peak calcium 
elevation induced by anti-CD3. Only cells responding to anti-CD3 
antibody are included in the analysis. Symbols represent mean  
SEM and summarize data from a total of 161 N1 cells (five separate 
experiments) and 181 B27 cells (six separate experiments). Statistical 
analysis was performed with the Mann-Whitney U Test and confirmed 
with the Wilcoxon Rank Sum Test.
Figure 3. Bcl-2 inhibits anti-CD3–induced calcium elevation, but 
not TG-induced calcium elevation. Cytoplasmic calcium elevation 
induced by anti-CD3 antibody and by TG was measured in parallel 
in multiple Bcl-2–positive and –negative clones described in Fig. 1. 
Cells were incubated in ECB containing 1.3 mM calcium until the 
beginning of recordings when EGTA was added to chelate extracellular 
calcium. Fluorometry tracings show the transient elevation of cyto-
plasmic calcium induced by anti-CD3 antibody (A) or by 100 nM 
TG (B). Histograms summarize the peak cytosolic calcium elevation 
induced by anti-CD3 antibody (C) or 100 nM TG (D) in multiple 
experiments (mean  SEM). F and G summarize multiple experiments 
(mean  SEM) in which peak calcium elevation induced by anti-CD3 
(E) and by 100 nM TG (F) was measured in WEHI7.2 cells stably 
expressing Flag-tagged wild-type Bcl-2 and Flag-tagged ER-targeted 
Bcl-2 or control expression vector (Neo).
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compared in Bcl-2–negative and –positive clones. A typical
continuous single cell tracing is shown in Fig. 4 C. Cells
were initially perfused with extracellular buffer (ECB) and
then with ICB supplemented with an ATP regenerating sys-
tem and digitonin. The 340:380 fluorescence emission ratio
increased dramatically when cells were permeabilized, re-
flecting a typically high ER luminal calcium concentration.
The calcium concentration was calculated from the steady-
state ratio in numerous experiments (Fig. 4 D). Two sets of
experiments were performed. The first consisted of a direct
comparison of N1 versus B27 cells, and the second set con-
sisted of a direct comparison of N2 versus B17 cells. Based
on these findings, there was no detectable difference be-
tween Bcl-2–positive and –negative cells in terms of free cal-
cium concentration within the ER lumen. In these experi-
ments, luminal calcium was allowed to come to steady-state,
provided with ATP by an ATP-regenerating system. In a dif-
ferent experimental approach, cells were perfused with 10
 

 
g/ml digitonin in ECB and luminal calcium concentration
was based on the 340:380 ratio at the time point where cells
were initially permeabilized. This alternative experimental
approach confirmed no difference in ER luminal calcium
concentration between Bcl-2–positive and –negative clones
(unpublished data). These findings indicate that the inhibi-
tory effect of Bcl-2 on anti-CD3–induced calcium elevation
was not due to a Bcl-2–imposed decrease in the mobilizable
ER calcium pool.
Thus, the inhibition of anti-CD3–induced calcium eleva-
tion by Bcl-2 is due either to Bcl-2–mediated interference
with the signal transduction pathway that mediates this re-
sponse or to a direct effect of Bcl-2 on InsP
 
3
 
R function.
 
Bcl-2 targets the InsP
 
3
 
R to inhibit calcium release
 
To exclude the first possibility, the signal transduction path-
way mediating the response to anti-CD3 antibody was by-
passed by measuring cytoplasmic calcium elevation after
addition of a cell-permeant InsP
 
3
 
 ester, D-myo InsP
 
3
 
hexakisbutyryloxymethyl ester (D-myo InsP
 
3
 
BM), to intact
Bcl-2–positive and –negative cells. After a brief delay re-
quired for de-esterification, D-myo InsP
 
3
 
BM induced an el-
evation in cytosolic calcium that had a shorter latency pe-
riod, a more rapid rate of increase, and a higher peak
amplitude in Bcl-2–negative cells compared with Bcl-2–pos-
itive cells (Fig. 5). These findings indicated that Bcl-2 acts at
Figure 4. Bcl-2 does not decrease luminal free calcium concentration. Free luminal ER calcium concentration was measured using the low 
affinity calcium sensitive dye Fura-2FF AM. (A) Intracellular localization of Fura-2FF fluorescence (left) and fluorescence from the mitochondrial 
dye TMRE (right) was detected as nonconfocal Z-series stacks followed by deconvolution. Bars, 5 m. (B) Typical single cell traces showing 
fluorescence emission at 340 and 380 nm excitation. Cells were loaded with Fura-2FF AM while suspended in ECB. Cells were then perfused 
with ICB supplemented with an ATP generating system and 10 g/ml digitonin. Fluorescence at both 340 and 380 nm decreased dramatically 
when cells were permeabilized by digitonin. Cells were then perfused with ICB containing 10 M InsP3 and 100 M MnCl2. Mn2 enters the 
ER and quenches luminal Fura-2FF after opening of InsP3Rs by InsP3. (C) Typical single cell traces monitoring the ratio of fluorescence at 340 
and 380 nm excitation. The 340:380 ratio increases rapidly when cells are permeabilized with digitonin. The 340:380 ratio gradually reaches 
steady-state levels. (D) Summary of luminal ER calcium concentration based on steady-state 340:380 ratios after cell permeabilization with 
digitonin. Measurements were performed in six experiments constituting parallel comparisons of 59 Neo1 control cells versus 50 B27 cells, 
and in 13 experiments constituting parallel comparisons of 180 Neo2 control cells versus 85 B17 cells. Symbols represent mean  SEM. 
Statistical analysis was performed with the Mann-Whitney U Test and confirmed with the Wilcoxon Rank Sum Test.
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the level of the ER to inhibit anti-CD3–induced calcium el-
evation, rather than interfering with upstream components
of the signal transduction pathway initiated by TCR activa-
tion.
To examine further if Bcl-2 was acting at the level of
InsP
 
3
 
Rs, the affinity of InsP
 
3
 
Rs for InsP
 
3
 
 was measured in
microsomes isolated from Bcl-2–positive and –negative cells
using a competitive binding assay. The 
 
K
 
d
 
 for radiolabeled
InsP
 
3
 
 binding was consistently higher in Bcl-2–positive mi-
crosomes than in Bcl-2–negative microsomes (7.0 
 

 
 1.3 nM
vs. 4.8 
 

 
 1.1 nM; P 
 
 
 
0.001), indicating that Bcl-2 de-
creases InsP
 
3
 
R binding affinity. To determine if decreased
InsP
 
3
 
 binding affinity fully explains the inhibitory effect of
Bcl-2 on InsP
 
3
 
-induced calcium elevation, the relationship
between InsP
 
3
 
 concentration and calcium release from the
ER was investigated. For this purpose, ER luminal calcium
was continuously monitored with the low affinity calcium
indicator Fura-2FF, before and after adding InsP
 
3
 
 to cells in
which the plasma membrane had been permeabilized by dig-
itonin. In typical calcium tracings, increasing concentrations
of InsP
 
3
 
 induced a stepwise decrease in Fura-2FF ratio, re-
flecting a stepwise decline in luminal calcium due to InsP
 
3
 
-
induced release of calcium into the cytoplasm (Fig. 6 A).
This finding was highly reproducible as shown in the InsP
 
3
 
dose response analysis and indicates that Bcl-2 inhibits the
extent of InsP
 
3
 
-induced calcium release from the ER even at
saturating InsP
 
3
 
 concentrations (Fig. 6 B). In contrast, the
extent of calcium release induced by TG was similar in Bcl-
2–positive and –negative cells (Fig. 6 C). These findings in-
dicate that Bcl-2 inhibits InsP
 
3
 
-induced calcium release,
even at saturating InsP
 
3
 
 concentrations well above the 
 
K
 
d
 
 for
InsP
 
3
 
 binding. Thus, an alteration in InsP
 
3
 
 binding affinity
does not fully explain the inhibition of InsP
 
3
 
-induced cal-
cium release by Bcl-2. Nevertheless, these findings further
Figure 5. Bcl-2 inhibits cytoplasmic calcium elevation induced 
by cell-permeant InsP3 ester. Cytosolic calcium concentration 
was measured by single cell calcium imaging using the calcium 
indicator Fura-2 AM in the presence of 1.3 mM extracellular calcium. 
(A) Representative calcium traces comparing Bcl-2–negative (N1) 
and –positive (B27) clones. (B) Summary of peak calcium concen-
tration induced by 25 M InsP3 ester in three separate experiments 
on a total of 42 N1 cells and 31 B27 cells. Symbols represent mean  
SEM and statistical analysis was performed with the Mann-Whitney
U Test and confirmed with the Wilcoxon Rank Sum Test.
Figure 6. Bcl-2 inhibits the extent of calcium release even at 
saturating concentrations of InsP3. Cells were loaded with Fura-2FF 
AM to monitor ER luminal calcium as described in Fig. 4. After cell 
permeabilization with digitonin, increasing concentrations of InsP3 
were added sequentially while continuously monitoring the Fura-2FF 
340:380 ratio. (A) Continuous recording of Fura-2FF ratio in neo 
control and Bcl-2 overexpressing WEHI7.2 cells. The stepwise 
decrease in the 340:380 ratio corresponds to the decline in luminal 
calcium secondary to InsP3-induced release of calcium into the 
cytoplasm. (B) Linear least squares dose response analysis of mul-
tiple experiments like that shown in panel A (symbols represent 
mean  SEM for nine separate experiments). (C) 1 M TG was 
added to intact unpermeabilized Fura-2FF–loaded cells and the 
Fura-2FF 340:380 ratio was monitored continuously. The decrease
in Fura-2FF ratio is due to a stepwise decline in luminal calcium 
induced by TG-mediated SERCA pump inhibition.
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suggest that Bcl-2 regulates cellular calcium signaling at the
level of the InsP3Rs.
Bcl-2 inhibits InsP3R channel opening in vitro
To determine if Bcl-2 regulates InsP3R channel activity, the
effect of purified full-length Bcl-2 protein on single type I
InsP3R channels was measured under steady-state condi-
tions. Single InsP3R channels were incorporated in planar
lipid bilayers. InsP3R channel incorporation was visualized
as a series of discrete positive (upward) current fluctuations
in the presence of 2 M InsP3 and 250 nM calcium in the
cis compartment (cytoplasmic side of the channel) as shown
in control traces in Fig. 7 A. A conductance of 300 pS and
reversal potential of 23 mV was measured from the cur-
rent–voltage relationship (unpublished data), correspond-
ing to those values expected for an InsP3R channel under
these experimental conditions (Ramos-Franco et al., 1998).
A reduction in single channel activity was observed upon ad-
dition of 0.1 M Bcl-2 in the compartment bathing the
cytoplasmic side (cis compartment) of the InsP3R channel
(Fig. 7 A). Conductance and reversal potential (unpublished
data) were not changed by adding Bcl-2. Thus, Bcl-2 only
reduces open probability without important changes in con-
duction or gating properties. To quantify the change in
open probability of the InsP3R channel induced by Bcl-2,
all-point histograms were constructed, permitting compari-
son of the relative areas for the control records and those ob-
tained after the addition of Bcl-2 (Fig. 7 B). For clarity, only
Gaussian distribution fits are shown. The total recording
time considered in the analysis for each condition was 9 s. In
the control situation (Fig. 7 B, dashed line), the closed state
appears as an accumulation of points near 0 pA, whereas the
open state is visualized as a peak at 8 pA. The probability
in absence of added Bcl-2 was 0.27, calculated as the ratio
between the area of the open state and the total area of the
histogram. Addition of Bcl-2 reduced the probability by 4.5-
fold to 0.058. This effect was seen as a reduction of the
height of the peak at the open state (without change in the
amplitude of the current) and a corresponding increase in
the amount of points at the closed level (Fig. 7 B, solid line).
Similar findings were obtained in experiments where the
current carrier was potassium instead of cesium (cis/trans
Figure 7. Bcl-2 reduces InsP3R channel open probability. Single 
InsP3Rs were incorporated into artificial planar lipid bilayers, and 
the effect of Bcl-2 on channel activity was studied after addition 
of 0.1 M purified full-length Bcl-2 to the solution bathing the 
cytoplasmic face of the channel. (A) Representative single channel 
traces showing the level of activity of a channel under control con-
ditions (top trace; cis/trans 220 mM CsCH3SO3/20 mM CsCH3SO3, 
pH 7.4) in the presence of 2 M InsP3. The holding potential was 0 
mV. Channel openings are seen as upward current deflections. The 
bottom trace shows the same InsP3R channel after addition of Bcl-2 
to the cis compartment (cytoplasmic side of channel). Bcl-2 signifi-
cantly reduces the open probability. The bar at the left indicates the 
zero current level (closed state). (B) All-points amplitude histogram 
of the experiment shown in A. The effect on open probability is 
demonstrated by a reduction of the peak representing the open level.
Figure 8. Bcl-2 is present in complexes with InsP3Rs. (A) Western 
blots showing levels of calnexin and cox IV in cell lysates and purified 
ER membrane from Bcl-2–expressing WEHI7.2 cells (clone 17). 
(B) Identification of protein complexes in purified ER membranes 
by BN-PAGE. MW, molecular size markers; ER, ER membrane. I–IV 
point to complexes that were cut from this gel and separated by 
SDS-PAGE. White line indicates that intervening lanes have been 
spliced out. (C) Complexes I–IV from B were resolved by SDS-PAGE 
and analyzed by Western blotting with antibody to Type III InsP3R 
(top) and antibody to human Bcl-2 (bottom).
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250/50 mM KCl; unpublished data). In this case, the total
recording time considered in the analysis was much longer
(120 s) for each condition. Addition of 0.1 M Bcl-2 to
the cytoplasmic face of the InsP3R reduced the channel open
probability by 2.92-fold. Potassium or cesium are com-
monly used instead of calcium because conductance of the
channel for monovalent cations is much higher than that for
divalent cations, improving the resolution (signal to noise
ratio) of single channel currents without significantly chang-
ing gating properties. In summary, these results demonstrate
an inhibitory interaction between Bcl-2 and InsP3Rs in
vitro.
Bcl-2 and InsP3Rs form a macromolecular complex in 
WEHI7.2 cells
To determine if Bcl-2 associates with InsP3Rs in vivo, ER
membranes were isolated from Bcl-2–expressing WEHI7.2
cells (clone 17) and subjected to blue native–PAGE (BN-
PAGE), a technique in which protein complexes are sepa-
rated in the first dimension on nondenaturing gels and pro-
tein complexes are then analyzed by SDS-PAGE/Western
blotting in the second dimension (Schagger et al., 1994).
Multiple high molecular mass complexes were resolved in
first dimension gels (Fig. 8 B). The four largest complexes
were cut from the gel and subjected to SDS-PAGE/Western
blotting (Fig. 8 C). The findings indicate that at least a por-
tion of Bcl-2 is located together with InsP3Rs in the largest
complex. Bcl-2 was also detected in the smaller complexes
analyzed, suggesting either that some of the Bcl-2 had disso-
ciated from the InsP3R complexes during preparation or that
not all of the Bcl-2 is associated with InsP3Rs.
The potential interaction of Bcl-2 and InsP3Rs was further
analyzed by coimmunoprecipitation (Fig. 9). InsP3Rs were
immunoprecipitated from Neo control cells (clone N1) and
Bcl-2–expressing cells (clone B17), and immunoprecipitates
were analyzed by Western blotting with an antibody specific
for Bcl-2 (Fig. 9 A). The results indicate that Bcl-2 coimmu-
noprecipitates with InsP3Rs. Bcl-2 coimmunoprecipitation
with InsP3Rs was detected using antibodies to each of the
three InsP3R subtypes (Fig. 9 B). In the reciprocal experi-
ment, Bcl-2 was immunoprecipitated and InsP3Rs were de-
tected as coimmunoprecitating proteins by Western blot-
ting, confirming the interaction between Bcl-2 and InsP3Rs
(Fig. 9 C). To control for the specificity of interaction be-
tween Bcl-2 and InsP3Rs, immunoprecipitates were also an-
alyzed by Western blotting using an antibody to SERCA3
(Fig. 9 D). This ER membrane protein did not coimmuno-
precipitate with either Bcl-2 or InsP3Rs. Because the associa-
tions described in Fig. 9 (A–C) were shown in cells overex-
pressing Bcl-2, we next examined if similar interactions
occurred in cells that endogenously expressed Bcl-2. For this
purpose, we took advantage of another T cell line, S49.A2,
Figure 9. Coimmunoprecipitation of Bcl-2 with InsP3Rs. (A) InsP3Rs 
were immunoprecipitated from N1 and B17 clones using a subtype 
nonspecific antibody. Immunoprecipitates were analyzed by Western 
blotting using an antibody to hBcl-2. The level of overexpressed 
human Bcl-2 is shown by Western blotting in the “no ip” lane. (B) 
InsP3Rs were immunoprecipitated from N1 and B17 cells using anti-
bodies that recognize either all three subtypes (left) or antibodies 
specific for each subtype (second through fourth panels). Immuno-
precipitates were analyzed by Western blotting using anti–human 
Bcl-2 antibody. (C) Human Bcl-2 (i.e., overexpressed Bcl-2) was 
immunoprecipitated, and immunoprecipitates were analyzed by 
Western blotting using antibody specific for InsP3R subtype III. The 
levels of type III InsP3Rs are shown by Western blotting in the “no ip” 
lane. (D) Bcl-2 and InsP3Rs were immunoprecipitated from the B17 
clone as described in preceding panels, and immunoprecipitates were 
analyzed by Western blotting using antibody to SERCA3. The level 
of SERCA3 in B17 cells is shown in the “no ip” lane. (E) Endogenous 
mouse Bcl-2 and InsP3Rs were immunoprecipitated from S49.A2 
cells using an antibody specific for mouse Bcl-2 and an antibody 
that reacts with all three subtypes of InsP3Rs, respectively. In all 
panels, the lanes labeled “IgG” represent immunoprecipitations 
performed using nonspecific IgG control antibodies. InsP3Rs were 
detected in Bcl-2 immunoprecipitates using antibody to Type III 
InsP3Rs (left), while endogenous Bcl-2 was detected in InsP3R 
immunoprecipitates by probing Western blots with an antibody to 
murine Bcl-2 (right). (F) Bcl-2 and InsP3Rs were immunoprecipitated 
from S49A2 cells as described in preceding panels, and immuno-
precipitates were analyzed by Western blotting using antibody 
to SERCA3. The level of SERCA3 in S49A2 cells is shown in the 
“no ip” lane.
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which has been demonstrated to express Bcl-2 (Wang et al.,
2003). Coimmunoprecipitation of endogenous Bcl-2 with
InsP3Rs, using either anti–Bcl-2 or anti-InsP3R antibody,
was detected in these cells (Fig. 9 E). SERCA3 did not coim-
munoprecipitate with either endogenous Bcl-2 or InsP3Rs
(Fig. 9 F). In summary, the findings of coimmunoprecipita-
tion experiments suggest that Bcl-2 forms a complex with
InsP3Rs.
Discussion
Here we report that Bcl-2 inhibits InsP3-induced calcium el-
evation in the WEHI7.2 T cell line. The focus has been on
understanding the mechanism by which Bcl-2 inhibits anti-
CD3–induced calcium elevation. The findings of a system-
atic series of experiments all point to a regulatory effect
of Bcl-2 on InsP3R function. First, the observation that
Bcl-2 inhibits anti-CD3–induced calcium elevation was con-
firmed in multiple Bcl-2–expressing clones of the WEHI7.2
line by both fluorometric and digital imaging methods of
calcium measurement. Second, an inhibitory effect of Bcl-2
on ER calcium release was detected when the signal trans-
duction pathway mediating anti-CD3–induced InsP3 syn-
thesis was bypassed by adding a cell-permeant InsP3 ester to
cells or by adding InsP3 to digitonin-permeabilized cells.
Third, anti-CD3–induced calcium elevation was inhibited
not only by wild-type Bcl-2, which localizes to both the ER
and mitochondria, but also by Bcl-2 selectively targeted to
the ER membrane. These findings indicate that the action of
Bcl-2 resides at the level of the ER, rather than in the up-
stream signal transduction pathway that mediates InsP3 syn-
thesis. Fourth, a series of control experiments indicated that
inhibition of InsP3-induced calcium release by Bcl-2 was not
due to decreased luminal calcium concentration, decreased
InsP3R levels, or altered expression of luminal calcium bind-
ing proteins. Fifth, Bcl-2 inhibited the extent of InsP3-
induced calcium release even at saturating InsP3 concentra-
tions, indicating that the major action of Bcl-2 is not to
decrease the affinity of InsP3Rs for InsP3 but to decrease
InsP3R channel opening even under conditions of maximal
stimulation. Although the complete mechanism is yet to
be determined, based on coimmunoprecipitation and BN-
PAGE experiments it appears that Bcl-2 coexists in a macro-
molecular complex with InsP3Rs, resulting in an inhibition
of InsP3-induced calcium release. This concept is further
supported by in vitro evidence that purified Bcl-2 inhibited
the frequency of InsP3 channel opening when added to
InsP3Rs integrated into planar lipid bilayers.
Although an inhibitory action of Bcl-2 on InsP3-mediated
calcium release has not been reported previously, an inhibi-
tory effect of Bcl-2 on calcium-mediated signaling pathways
has been reported, including the induction of the transcrip-
tion factor c-fos (Qi et al., 1997). Significantly, Linette et al.
(1996) demonstrated that Bcl-2 inhibits anti-CD3/TCR–
mediated activation of NFATc and induction of interleukin-
2 (IL-2) expression, thereby inhibiting cell cycle entry by de-
laying Go/G1 transition into S phase and also inhibiting
TCR activation-mediated apoptosis. Active NFATc is gener-
ated by calcineurin, which binds to and dephosphorylates
NFATc in the cytoplasm, permitting NFATc to enter the
nucleus. It has been suggested that Bcl-2 inhibits NFATc ac-
tivation by sequestering calcineurin to intracellular mem-
branes (Shibasaki et al., 1997). Our findings suggest that
Bcl-2 may inhibit calcineurin activation by inhibiting InsP3-
mediated calcium release from the ER. In T cells, calcium/
calcineurin-mediated activation of NFATc increases IL-2 ex-
pression, which in turn stimulates dual pathways, one lead-
ing to cell death and the other leading to cell survival. IL-2
induces cell death via Stat2-mediated induction of the death
receptor ligand Fas, whereas IL-2 promotes cell survival via
Akt-mediated induction of Bcl-2 expression (Parijs et al.,
1999). The findings of the present paper raise the possibility
that increased expression of Bcl-2 may form a feedback loop
that dampens InsP3-mediated calcium signals, thereby con-
trolling T cell proliferation while maintaining cell survival.
InsP3Rs are known to associate with several factors that
regulate InsP3-gated channel activity (Mackrill, 1999; Rod-
erick and Bootman, 2003). This paper is the first to suggest
that Bcl-2 may interact with InsP3Rs and regulate their func-
tional activity. Although the full functional significance of
the inhibitory effect of Bcl-2 on InsP3R channel activity is as
yet unknown, this action of Bcl-2 may contribute to the es-
tablished inhibitory effects of Bcl-2 on cell cycle entry and/
or apoptosis induction. In view of the wide range of cellular
functions mediated by InsP3-induced calcium signals (Ber-
ridge et al., 2003), it will be interesting in future studies to
determine if the function of Bcl-2 goes beyond that of regu-
lating cell cycle entry and apoptosis.
Materials and methods
Reagents
TG, EGTA, digitonin, and other reagents were obtained from Sigma-
Aldrich. D-myo-InsP3 and L-myo-InsP3 were obtained from Calbiochem.
Fura-2 AM was obtained from Molecular Probes. Fura-2FF AM was ob-
tained from Tef Labs. Hamster anti–mouse CD3e epsilon chain mAb was
obtained from BD Biosciences.
Cell culture and transfection procedures
WEHI7.2 and S49.A2 cells were cultured in DME supplemented with 10%
serum, L-glutamine, and nonessential amino acids. Human Bcl-2  cDNA
from the pB4 plasmid (American Type Culture Collection) was cloned into
the pSFFV-Neo vector. Transfection and cloning were performed as de-
scribed previously (Dieken and Miesfeld, 1992). Flag-tagged Bcl-2 was se-
lectively localized to the ER by exchanging the COOH-terminal transmem-
brane sequence of Bcl-2 for the ER-targeting sequence of cytochrome b5,
as described previously (Wang et al., 2001). Bcl-2 expression was moni-
tored by flow cytometry of fixed cells using anti–Bcl-2 antibody (BD Bio-
sciences; 15131A) at a 1:500 dilution and Alexa Fluor 488 goat anti–ham-
ster IgG (HL) conjugate (Molecular Probes; A-21110) as the secondary
antibody at a dilution of 1:500.
Calcium fluorometry
Cells (10 ml volume, 1 million per milliliter) were incubated with 1 M
Fura-2 AM for 45 min at 25C in ECB (130 mM NaCl, 5 mM KCl, 1.5 mM
CaCl2, 1 mM MgCl2, 25 mM Hepes, pH 7.5, 1 mg/ml BSA, and 5 mM glu-
cose), after which they were pelleted and resuspended in ECB for an addi-
tional incubation at 25C for 30 min to permit dye de-esterification. Fluo-
rescence was continuously recorded at 37C (alternating 340 and 380 nm
excitation, 510 nm emission) in a fluorometer (Photon Technology Inc.).
EGTA (final concentration 10 mM) was added to chelate extracellular cal-
cium immediately before adding 100 nM TG, anti-CD3 antibody (BD Bio-
sciences; 1:150 dilution), or 25 M D-myo InsP3BM. In experiments using
D-myo InsP3BM, the volume of cell suspensions was scaled down to 250
l in a 300 l cuvette. All measurements were performed in triplicate. Rmax
and Rmin values were determined in each experiment by cell permeabiliza-
tion with digitonin, followed by sequential addition of calcium and EGTA/
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Tris. Calcium concentration was calculated, based on the published Kd for
Fura-2 of 220 nM, by the equation of Grynkiewicz et al. (1985) using Felix
Software (Photon Technologies Inc.).
Calcium imaging
Cells adhered to poly-L-lysine–coated coverslips (15 mm) were loaded
with 1 M Fura-2 AM (Molecular Probes) as described in Calcium fluo-
rometry. Coverslips were placed in a recording/perfusion chamber (model
RC-25F; Warner Instruments) mounted on the stage of an inverted micro-
scope (model Diaphot; Nikon) equipped with a 20 Fluor objective. Exci-
tation light was alternated between 340 and 380 nm by a filter wheel (Sut-
ter Instrument Co.) and emitted light was filtered at 510 nm and
collected with an intensified charge-coupled device camera (model Ul-
traPix; PerkinElmer). The video signal was digitized using Ultraview soft-
ware (PerkinElmer) and subsequently processed using Microsoft Excel.
Cells were perfused with ECB at 25C and stock solutions of both anti-CD3
antibody (1:40 dilution) and 25 M D-myo InsP3BM were diluted in ECB
immediately before addition to the perfusion chamber. To determine Rmin,
cells were perfused with ECB deficient in calcium and supplemented with
4 mM EGTA and 10 M ionomycin. Rmax was obtained by perfusing cells
with ECB supplemented with 4 mM CaCl2 and 10 M ionomycin. Calcium
concentration was calculated as described in Calcium fluorometry.
ER calcium measurement
Luminal calcium measurement was modified after that of Hofer (1999).
Cells adhered to poly-L-lysine–coated coverslips were incubated with 1
M Fura-2FF AM for 30 min at 37C in ECB, after which the buffer was re-
placed with fresh ECB and the incubation continued for 45 min at 25C to
permit de-esterification. Cell imaging was performed as described in Cal-
cium imaging. Cells were initially perfused with ECB at 25C, and then
with ICB (125 mM KCl, 25 mM NaCl, 10 mM Hepes, 0.5 mM Na2ATP,
200 M CaCl2, and 500 M EGTA, pH 7.25), supplemented with an ATP-
regenerating system consisting of 10 g/ml creatine phosphokinase Type I
and 10 mM phosphocreatine. As soon as cells were permeabilized, the
perfusion buffer was switched to ICB plus ATP-regenerating system. After
the fluorescence ratio reached steady-state, cells were perfused with the
same buffer supplemented with D-myo-InsP3 at concentrations given in the
text and accompanying figures. Stock solutions of D-myo-InsP3 and L-myo-
InsP3 were prepared at a concentration of 3 mM in calcium-free water and
stored at 	20C until use. After cell permeabilization with digitonin, the
proportion of Fura-2FF located in the ER was determined by quenching lu-
minal dye by perfusing with 10 M D-myo-InsP3 in ICB supplemented
with 100 M MnCl2. To determine Rmin, permeabilized cells were perfused
with ECB deficient in calcium and supplemented with 4 mM EGTA and 10
M ionomycin. Rmax was obtained by perfusing permeabilized cells with
ECB supplemented with 4 mM CaCl2.
The InsP3 dose response relationship was determined by sequential ad-
dition of D-myo-InsP3 to digitonin-permeabilized cells while continuously
monitoring the Fura-2FF 340:380 ratio. The InsP3-mediated change in the
340:380 ratio was plotted as a function of InsP3 concentration by nonlinear
least squares best fit of the data to the Langmuir isotherm equation using
Origin 6.0 (Microcal).
Organelle imaging
Confocal Z-series stacks of TMRE-loaded (0.1 M, 10 min) cells were ac-
quired after permeabilization with digitonin in ICB at RT using an Ultra
View LCI (PerkinElmer) with a microscope (model TE300; Nikon), 100/
1.3 objective (Nikon), and Orca ER camera (Hamamatsu) at excitation 568
nm, emission 600  40 nm. The laser intensity was kept at a minimum to
prevent irradiation-induced mitochondrial damage. Image acquisition was
by UltraView software (PerkinElmer). Nonconfocal Z-series stacks of Fura-
2FF loaded cells were obtained after permeabilization with digitonin in
ICB at RT using an Ultra View LCI with a microscope, 100/1.3 objective,
epifluorescence arc-lamp as a light source (excitation 330–380 nm, di-
chroic 400LP, emission 420LP), and Orca ER camera. Subsequent image
restoration was achieved with the deconvolution software AutoDeblur
(Autoquant).
Western blotting
Cell lysates containing 40–60 g of protein were separated by SDS-PAGE
(15% for Bcl-2 and 4–15% linear gradient for InsP3Rs) followed by electro-
phoretic transfer onto Immobilon-P PVDF membranes (Millipore). The fol-
lowing antibodies and their respective dilutions were used: anti–human
Bcl-2 (BD Biosciences; 15131A, 1:2000), anti–mouse Bcl-2 (BD Bio-
sciences; 554218, 1:1000), anti-actin (Santa Cruz Biotechnology, Inc.;
sc-8432, 1:1000), anti-InsP3R Type I (Calbiochem; 407144, 1:2000), anti-
InsP3R Type II (Chemicon; AB3000, 1:100), anti-InsP3R Type III (BD Bio-
sciences; 610312, 1:2000), and anti-SERCA3 ATPase (Affinity Bio-
Reagents, Inc.; PA1-910, 1:500).
BN-PAGE
ER membranes were isolated from WEHI7.2 cells as described previously
(Krajewski et al., 1993). In brief, cells (1–10  108) were washed twice
with ice-cold PBS (Invitrogen), pH 7.2, and resuspended in 1.5 ml of ho-
mogenization buffer (20 mM Hepes, pH 7.4, 2.5 mM EDTA, 250 mM su-
crose, and protease inhibitor cocktail). After homogenization for 15–25
strokes with a Dounce homogenizer, samples were centrifuged at 3,000 g
for 15 min at 4C and 1 ml of supernatant was layered onto an 11-ml su-
crose gradient (0.75 to 1.9 M sucrose in 20 mM Hepes, pH 7.4, and 2.5
mM EGTA) and centrifuged at 110,000 g for 2 h at 4C. Sequential frac-
tions of 0.8 ml were collected from the gradient and the distribution of ER
and mitochondria was determined by Western blotting. Calnexin (anti-cal-
nexin antibody, SPA-8600; StressGen Biotechnologies) and Cox IV (anti IV
COX, A-6403; Molecular Probes) were used as markers of ER and mito-
chondria, respectively. Fractions containing purified ER membranes were
pooled and mixed with three volumes of 20 mM Hepes, pH 7.4. The sam-
ple was centrifuged at 105,000 g for 1.5 h at 4C and the resulting mem-
brane pellet was used for BN-PAGE, performed as described previously
(Schagger et al., 1994). The ER membrane was solubilized with 750 mM
6-aminocaproic acid, 50 mM BisTris, pH 7.0, and 1% dodecyl maltoside
(5 g total protein per microliter), and centrifuged at 100,000 g for 15 min
at 4C. Before starting BN-PAGE, Coomassie blue was added to the result-
ing supernatant to 0.25%. 100 g of protein was added to each well of
4–10% linear gradient BN-PAGE. Single bands were excised from the blue
native gel and applied to a 4–20% linear gradient SDS-PAGE with sample
buffer, followed by Western blotting. Sizes of molecular complexes were
estimated using a high molecular mass calibration kit for native electro-
phoresis (17–0445-01; Amersham Biosciences). After completion of elec-
trophoresis, gels were subjected to Western blotting using antibodies to
InsP3Rs and human Bcl-2 as described above.
Immunoprecipitation
108 cells were washed twice with PBS and incubated on ice 30 min with 1
ml lysis buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2 mM EDTA, 1%
CHAPS wt/vol, 50 mM NaF, 200 nM okadaic acid, 1 mM Na3VO4, and
protease inhibitor cocktail [Complete Mini; Roche Applied Science]). Cell
lysates were centrifuged at 20,000 g for 15 min at 4C. The resulting super-
natant was rotated with 100 l of 50% protein A or protein G agarose
beads at 4C for 2 h. After removing the beads, the supernatant was incu-
bated with one of the following antibodies: anti–human Bcl-2 (hamster
1:250), anti–mouse Bcl-2 (1:250), anti-InsP3R antibody (anti-Type I, 1:200;
anti-Type II, 1:150; anti-Type III, 1:200; or antibody recognizing all three
subtypes [Calbiochem; 407143]) overnight at 4C, followed by rotation
with 50 l protein A or G agarose for 2 h at 4C. Nonspecific control anti-
bodies used were rabbit serum (1:200 dilution; Life Technologies) and
hamster IgG (5 g/ml; BD Biosciences). The beads were washed four times
with lysis buffer and boiled for 5 min in 50 l sample buffer. The eluted
proteins were resolved by SDS-PAGE and analyzed by Western blotting.
InsP3 binding
Specific binding of radiolabeled InsP3 to microsomes was measured as de-
scribed previously (Riley et al., 2002). Microsomes (50 g) were added in
duplicate to 100 l binding buffer (2 nM 3H-InsP3 [Dupont NET-911], 2
mM Tris, pH 9.0, 1 mM EDTA, and 1 mg/ml albumin, with or without a
range of concentrations of unlabeled InsP3) and incubated on ice for 20
min. The mixture was centrifuged for 15 min at 20,000 g at 4C. Pellets
were solubilized in 100 l water and added to 10 ml ACS scintillation
cocktail (Amersham Biosciences) and their activity was determined by liq-
uid scintillation counting. Nonspecific binding was determined using an
excess of unlabeled InsP3. The Kd was calculated by Scatchard analysis.
Planar lipid bilayer analysis of InsP3R channel activity
Full-length human Bcl-2 was purified from Escherichia coli M-15 (pRep-4)
cells transformed with a pProex-1/hBcl-2 using methods described previ-
ously (Lam et al., 1998). Type I InsP3Rs were purified from microsomes iso-
lated from COS-1 cells transfected with pInsP3R1-DT1-ALT plasmid as
described previously (Mignery et al., 1989, 1990). Gradient fractions
containing InsP3R protein were then identified by immunoblotting with
Type 1 receptor antibody and reconstituted into proteoliposomes as previ-
ously described (Mignery et al., 1992; Perez et al., 1997). Planar lipid bi-
layers were formed across a 150-m diameter aperture in the wall of a
Delrin partition as described previously (Perez et al., 1997). Proteolipo-
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somes were added to the solution on one side of the bilayer (defined as the
cis-chamber). The other side was defined as the trans-chamber. Standard
solutions contained 220 mM CsCH3SO3 cis (20 mM trans), 20 mM Hepes,
pH 7.4, and 1 mM EGTA ([Ca2]Free 
 250 nM). A custom current/voltage
conversion amplifier was used to optimize single-channel recording. Ac-
quisition software (pClamp; Axon Instruments, Inc.), an IBM compatible
486 computer, and a 12-bit A/D-D/A converter (Axon Instruments, Inc.)
were used. Single channel data were digitized at 5–10 KHz and filtered at
1 KHz. Channel sidedness was determined by InsP3 sensitivity. The orien-
tation of the channels studied was such that the InsP3 sensitive side (i.e.,
cytoplasmic side) was in the cis compartment.
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